Homeostasis in the Drosophila midgut is maintained by stem cells [1, 2] . The intestinal epithelium contains two types of differentiated cells that are lost and replenished: enteroendocrine (EE) cells and enterocytes (ECs). Intestinal stem cells (ISCs) are the only cells in the adult midgut that proliferate [3, 4] , and ISC divisions give rise to an ISC and an enteroblast (EB), which differentiates into an EC or an EE cell [3] [4] [5] . If the midgut epithelium is damaged, then ISC proliferation increases [6] [7] [8] [9] [10] [11] [12] . Damaged ECs express secreted ligands (Unpaired proteins) that activate Jak-Stat signaling in ISCs and EBs to promote their proliferation and differentiation [7, 9, 13, 14] . We show that the Hippo pathway components Warts and Yorkie mediate a transition from low-to high-level ISC proliferation to facilitate regeneration. The Hippo pathway regulates growth in diverse organisms and has been linked to cancer [15, 16] . Yorkie is activated in ECs in response to tissue damage or activation of the damage-sensing Jnk pathway. Activation of Yorkie promotes expression of unpaired genes and triggers a nonautonomous increase in ISC proliferation. Our observations uncover a role for Hippo pathway components in regulating stem cell proliferation and intestinal regeneration.
Homeostasis in the Drosophila midgut is maintained by stem cells [1, 2] . The intestinal epithelium contains two types of differentiated cells that are lost and replenished: enteroendocrine (EE) cells and enterocytes (ECs). Intestinal stem cells (ISCs) are the only cells in the adult midgut that proliferate [3, 4] , and ISC divisions give rise to an ISC and an enteroblast (EB), which differentiates into an EC or an EE cell [3] [4] [5] . If the midgut epithelium is damaged, then ISC proliferation increases [6] [7] [8] [9] [10] [11] [12] . Damaged ECs express secreted ligands (Unpaired proteins) that activate Jak-Stat signaling in ISCs and EBs to promote their proliferation and differentiation [7, 9, 13, 14] . We show that the Hippo pathway components Warts and Yorkie mediate a transition from low-to high-level ISC proliferation to facilitate regeneration. The Hippo pathway regulates growth in diverse organisms and has been linked to cancer [15, 16] . Yorkie is activated in ECs in response to tissue damage or activation of the damage-sensing Jnk pathway. Activation of Yorkie promotes expression of unpaired genes and triggers a nonautonomous increase in ISC proliferation. Our observations uncover a role for Hippo pathway components in regulating stem cell proliferation and intestinal regeneration.
Results and Discussion
Yorkie (Yki) is negatively regulated by the Warts (Wts) kinase, which promotes its cytoplasmic localization [17] [18] [19] [20] [21] . To investigate potential roles for the Hippo pathway in the development or physiology of the intestine, we analyzed the consequences of Yki activation. Yki was activated by either mutation or RNA interference (RNAi)-mediated depletion of wts, or else by expression of an activated form of Yki (Yki S168A :V5) [22] , which contains a mutation in a key Wts phosphorylation site. To restrict Yki activation to adult stages, we made use of the TARGET system [23] , in which a gene or RNAi line of interest is expressed under UAS-Gal4 control, and then tight temporal control is provided by simultaneous expression of a temperature-sensitive transcriptional repressor of Gal4-driven expression (Gal80 ts ). In initial experiments, endogenous Yki was activated throughout the adult fly by using a wts hairpin transgene (wts RNAi) expressed under tub-Gal4 control to deplete endogenous Wts. This resulted in a pronounced hyperplasia of the intestine, with many tightly packed cells, and a thicker intestinal epithelium (Figures 1B and 1C ; see also Figures S1A-S1C available online). This was accompanied by an apparent increase in intestinal stem cell (ISC) proliferation, as revealed by staining for expression of the Notch ligand Delta (Dl) ( Figure 1C ; Figure S1C ). Normally, Dl is specifically expressed in ISCs within the intestine and is lost from the enteroblast (EB) daughter cell when ISCs divide [5] . However, toxins, infection, or Jnk pathway activation can substantially increase numbers of Dl-expressing cells [6, 8, 9, 11, 12] , apparently because the loss of Dl expression in EBs is slow compared to the increased proliferation rate of ISCs. The intestinal hyperplasia and increased number of Dl-expressing cells imply that Hippo signaling normally functions to limit cell numbers in the intestine, at least in part by keeping ISC proliferation at a low level.
To confirm the role of Wts and Yki in ISC proliferation and to identify the cell types in which they function, we employed celltype-specific Gal4 drivers. As markers of progenitor cells, we used both Dl and escargot (esg), which is expressed specifically in ISCs and EBs [3] . Surprisingly, when Yki S168A :V5 was expressed in the ISC and EB under esg-Gal4 control (Figure S1M ), no effect on intestinal morphology or progenitor cell numbers was detected, even 10 days after induction of Yki S168A :V5 expression ( Figure 1D ). Thus, Yki activation in ISCs does not affect their proliferation. Visceral muscle cells adjacent to the intestinal epithelium have been reported to promote ISC proliferation by expressing Wingless [24] . To examine whether Yki acts in muscle cells to promote ISC proliferation, we expressed Yki S168A :V5 using How-Gal4, which drives expression in muscles [25] (Figures S1G and S1H) . Although a patchy increase in progenitor cells was detected at longer time points (10 days after induction; Figure S1F ), hardly any effect was observed at shorter time points (3 days after induction of Yki S168A :V5; Figure S1E ). By contrast to the relatively modest or undetectable consequences of Yki activation in muscles or ISCs, Yki activation in the differentiated enterocytes (ECs) of the intestinal epithelium resulted in a rapid and dramatic hypertrophy (Figure 1 ). Yki S168A :V5 was expressed specifically in ECs using Myo-IaGal4 [9] (Figures S1I-S1L ). The resulting intestinal overgrowth was associated with multiple layers of intestinal cells (Figure 1H) , by contrast to the normal monolayer ( Figure 1G) . Moreover, the intestinal lumen filled with cells ( Figure 1H ), presumably sloughed off from the overproliferating intestinal epithelium. The intestinal hypertrophy was accompanied by a substantial increase in numbers of Dl-and esg-expressing cells ( Figures 1I and 1J ). esg-lacZ was no longer restricted to adjacent pairs of cells (the ISC and EB) (Figures 2F; Figure S1M ) but instead was detected in many cells that morphologically appear to be ECs (recognizable by their large size and large, polyploid nucleus) ( Figure 1I ). We suggest that this reflects both the accelerated proliferation and differentiation of progenitor cells, as well as the stability of b-galactosidase. Confirmation that activation of endogenous Yki specifically within ECs also increases Dl-expressing progenitor cells was provided by examination of intestines in which Wts was depleted from ECs by TARGET-controlled induction of wts RNAi under MyoIa-Gal4 control, which resulted in accumulation of small Dl-expressing cells basal to the large, MyoIa-expressing ECs ( Figures 1K and 1L ). These observations imply that Yki activation in ECs exerts a strong, nonautonomous influence on the proliferation of ISCs.
To directly visualize this increased proliferation, we stained for cells in mitosis using anti-phospho-Ser10-Histone H3 (pH3) and labeled cells in S phase using EdU. When Yki was activated specifically in ECs using MyoIa-Gal4 to drive expression of Yki S168A :V5 or wts RNAi, then the number of cells labeling for pH3 and EdU increased substantially ( Figures  1M-1Q ). pH3 staining was only detected in small, scattered cells, which we infer are ISCs, based on their distribution and morphology ( Figure 1P ). This implies that activation of Yki does not cause the normally nonproliferating EBs, enteroendocrines (EEs), or ECs to proliferate, but rather increases the proliferation rate of ISCs. ISC proliferation is normally very low, and we detected an average of two pH3-staining mitoses per adult posterior midgut in control animals, consistent with prior studies ( Figure 1Q ) [9] . By contrast, wts-RNAi-treated posterior midguts averaged 55 pH3-staining mitoses (Figure 1Q ). EdU labeling was increased not only in ISCs but also in ECs ( Figures 1M-1P ). ECs become polyploid through endoreplication; the increased DNA synthesis might reflect a more rapid differentiation of ECs [9] and/or an increase in polyploidy, which could enable the cells to grow larger.
To further characterize the nonautonomous influence of Yki activation on ISC proliferation, we generated clones of cells with activated Yki. Induction of Yki S168A :V5 expression in clones using the Flp-out technique, which enables expression to be induced in nondividing cells [26] and thus allows induction of expression directly in ECs, resulted in a rapid, nonautonomous increase in esg-lacZ-expressing cells ( Figure 2C ). Induction of clones by mitotic recombination is limited to dividing cells, which means that such clones can only be induced in the ISC. However, after waiting several days, these clones can increase in size through subsequent divisions of the ISC and can include ECs differentiated from EB daughter cells within the clone. Mitotic recombination was coupled to the MARCM technique to make clones of cells expressing Yki S168A :V5 or mutant for wts. Both of these methods of Yki activation also nonautonomously increased ISC proliferation, based on examination of esg and Dl, as well as direct examination of proliferation using pH3 or EdU labeling (Figures 2; Figure S2 ). Activation of Yki did not block differentiation, because MARCM clones with activated Yki, which must have been induced in dividing ISCs, could include cells with large nuclei, which expressed Pdm1, a marker of differentiated ECs ( Figure S2E ). Based on EdU labeling, pH3 staining, esglacZ expression, or Dl expression, the range of the nonautonomous response to Yki activation in EC cells could extend for several cells (Figure 2 ).
The nonautonomous influence of Yki activation on ISC proliferation implies that activation of Yki in ECs leads to production of a secreted signal that can influence ISC proliferation. Several manipulations that can influence intestinal cell proliferation have been identified, including expression of Wg in visceral muscle cells [24] , mutation of Notch in ISCs [3, 4] , activation of the Jnk pathway in ECs [6, 7, 9, 12] , and activation of the Jak-Stat pathway in ISCs [7, 9, 13, 14] . The Jak-Stat pathway was a candidate effector of the influence of activated Yki, because ligands for this pathway are expressed in ECs in response to damage, infection, or activation of Jnk signaling, and activation of the pathway within ISCs in response to secreted Upd ligands promotes their proliferation [7, 9, 13, 14] . Additionally, like Wts and Yki, Jak-Stat and Jnk signaling have rapid effects on ISC proliferation, visible in less than 2 days, whereas manipulations of Wg or Notch signaling require longer times for significant effects on proliferation to be observed. Indeed, using an upd-lacZ reporter, we found that upd was barely detected in control intestines but was readily detected after activation of Yki in ECs ( Figures 3A and 3B) . The upd locus includes three related genes, upd1 (os), upd2, and upd3. To examine the expression of individual upd genes, and to quantify their expression, we performed quantitative reverse transcriptase-polymerase chain reaction on intestines with activated Yki in ECs. Expression of upd3 increased approximately 25-fold, whereas upd1 and upd2 increased 7-to 8-fold ( Figure 3L ). This upregulation resulted in a visible increase in Jak-Stat pathway activity, as monitored by expression of a Stat-DGFP reporter [27] (Figures 3C and 3D ). Based on cellular morphology, Stat-DGFP was upregulated most strongly in ISCs and EBs, but it was also visibly upregulated in other intestinal cells. These observations suggest that activation of Yki in ECs promotes ISC proliferation and intestinal hyperplasia by inducing expression of upd genes, which are secreted from ECs and then activate the Jak-Stat pathway in ISCs and EBs to promote their proliferation and differentiation.
To test this hypothesis, we used RNAi to simultaneously reduce expression of wts and hopscotch (hop), which encodes the Drosophila Jak kinase. Because wts is required in ECs, whereas Jak-Stat signaling is required in ISCs, tub-Gal4 was used to reduce the levels of both genes in both cell types. The increases in Dl expression and pH3-staining cells normally associated with wts RNAi were reduced by RNAi of hop (Figures 3I-3K ; Figure S3 ), whereas neutral upstream activating sequence (UAS) transgenes (i.e., UAS-GFP) did not affect wts RNAi phenotypes. In a second approach, mitotic recombination was used to make clones doubly mutant for wts and stat92E, which encodes the DNA-binding transcription factor of the Jak-Stat pathway. The influence of stat92E on ISC proliferation in these experiments was assayed by counting the number of cells within each clone. Clone size was significantly reduced using either of two different stat92E alleles ( Figures 3E-3H ). As expected, nonautonomous effects of wts on ISC proliferation were not blocked ( Figure 3F ). Thus, both experimental approaches confirm that the influence of Yki activation on Jak-Stat signaling contributes to its effect on ISC proliferation. The suppression was incomplete, which might be due to residual Hop or Stat or to production of additional mitogens, acting via other pathways, induced by Yki activation in ECs.
The observation that reducing wts levels increases ISC proliferation indicates that Wts is normally active in ECs and needs to be active there to prevent excess ISC proliferation. In order to investigate whether Yki has a normal role in promoting endogenous levels of ISC proliferation, we employed RNAi-mediated knockdown of yki in EC cells. Antibody staining confirmed that RNAi reduced levels of Yki ( Figure 4B ; data not shown). However, even after 7 to 10 days, the overall size of the intestine and number of ISCs was similar or only modestly reduced compared to that in control animals. This suggests that endogenous levels of Yki are not required for maintaining intestinal homeostasis in healthy animals, although this is subject to the caveat that some residual Yki was detected in RNAi-treated intestines.
Expression of upd genes is normally very low in intestinal cells but is upregulated in response to damage or infection to trigger a regenerative response that induces ISC proliferation [7, 9, 13, 14] . To investigate whether Yki has a role in damage response, we treated animals with bleomycin, a (B-P) Portions of the adult posterior midgut stained for DNA (blue, using DAPI), esg (green, using esg-lacZ or esg-Gal4 and UAS-GFP), Arm (red), Actin (green, using phalloidin), pH3 (green), EdU (red), or Dl (red/white), as indicated. Panels marked prime show individual channels of the stain to the left. DNA-damaging agent that induces a regenerative response in the intestine [11] . The increase in Dl-expressing progenitors associated with bleomycin treatment ( Figure 4A ) was reduced by RNAi of yki ( Figure 4B ). The increase in ISC mitosis associated with bleomycin (visualized by pH3 staining) was also reduced by yki RNAi, to about half the level in sibling controls ( Figures 4C-4E ). These observations indicate that the damage-response pathway activated by bleomycin acts at least in part through Yki. Consistent with this, Yki localization was altered in bleomycin-treated intestines. In wild-type, Yki is predominantly cytoplasmic ( Figure 4I ) [19, 20] , but in ECs of bleomycin-treated intestines, increased Yki could be detected within the nucleus of many cells ( Figure 4H ), which is a hallmark of Yki activation [19, 20] . Additionally, a transcriptional reporter of Hpo signaling, ex-lacZ [28] , was upregulated ( Figure 4G ). Thus, a toxin that damages ECs can induce Yki activation. Analysis of intestinal regeneration and upd expression has implied that there are multiple, parallel mechanisms by which infection or tissue damage can upregulate upd genes [7, 9, 13] . Many of these act through the Jnk signaling pathway, which mediates responses to tissue damage in diverse contexts, including toxins, aging, and infection. Direct activation of Jnk signaling can also induce intestinal hyperplasia and expression of upd genes [6, 7, 9, 12] . Thus, we investigated whether Jnk is involved in mediating the effects of tissue damage on Yki. Indeed, direct activation of Jnk signaling in ECs, achieved by expression of an activated form of the Jnk-kinase Hemipterous (Hep), Hep CA , using MyoIa-Gal4 or Gal4-expressing clones, increased nuclear Yki localization ( Figures 4J and 4K) . Thus, Jnk activation can promote Yki activation. Consistent with Jnk acting upstram of Yki, we observed that inhibition of Jnk signaling, achieved by expressing a dominant-negative form of the Drosophila Jnk Basket (Bsk), Bsk DN , which blocks Jnk pathway activation in the intestine [6, 9, 12] , did not block the influence of Yki S168A :V5 on ISC proliferation (Figures S4A and S4B) . We also note that, unlike Jnk pathway activation, Yki activation did not induce visible apoptosis or caspase cleavage (Figures S2C and S2D) .
Our results establish that two Hippo pathway components, Wts and Yki, play a crucial role in a damage-response pathway ( Figure S4C ). Activation of Yki promotes the expression of cytokines that promote the proliferation and differentiation of ISCs. Because Jnk signaling is generally activated by tissue damage and infection, the discovery that Yki is activated by Jnk signaling in the intestine raises the possibility that Hippo signaling might play a general role in regenerative responses to tissue damage. This possibility also suggests a convergence between the role of Hippo signaling in cancer biology [17, 29] and the role of infection and tissue damage in oncogenesis [30, 31] .
Hippo signaling can have both autonomous and nonautonomous effects on growth [32, 33] , and we report here that in the adult Drosophila midgut, Yki has profound nonautonomous effects on growth via the Jak-Stat pathway. Jak-Stat signaling is important for proliferation control and stem cell biology, not only in the Drosophila intestine, but also in other tissues, both in Drosophila and in vertebrates [34] [35] [36] . Members of the interleukin (IL) family of cytokines are homologous to Upd ligands, and a microarray study in cultured mammalian cells found that the Yki homolog Yap could regulate IL cytokines [37] , which raises the possibility that a regulatory connection between Hippo signaling and Jak-Stat signaling might be conserved. Increased levels and nuclear localization of Yap have been reported in colon cancer patient samples [16] , and ubiquitous Yap1 overexpression causes overproliferation of progenitor cells in the murine intestine [15] . Our observations suggest that future considerations of the potential contributions of Hippo signaling to colon cancer should include evaluations both of its possible regulation by Jnk signaling and of possible nonautonomous effects mediated by cytokines.
Experimental Procedures
Drosophila Genetics Conditional expression in adult flies using tub-Gal80 ts was achieved by maintaining flies at 18 C throughout their development and then shifting 6-to 8-day-old (at 18 C) adult females to a higher temperature for induction of gene expression. Initial experiments employed a shift to 30 C, but we found later that a shift to 28.5 C was also effective. For wts conditional RNAi, Tub-Gal80 ts /CyO; Tub-Gal4 UAS-dcr2/TM6b, MyoIA-Gal4/CyO; Tub-Gal80 ts UAS-dcr2/TM6b, or MyoIA-Gal4 Tubgal80 ts UAS-GFP/CyO; UAS-dcr2/TM6B flies were crossed to UAS-wts-RNAi (vdrc9928). :V5/(TM6B) was crossed to y w hs-FLP Tub-Gal4 UAS-GFP/FM7; Tub-Gal80 FRT40A/CyO. For wts and stat92E MARCM clones, y w hs-FLP Tub-Gal4 UAS-GFP; UAS-y + /(CyO); FRT82B tub-gal80/TM6B was crossed to w; wts X1 FRT82B/TM6B, w; stat92E 85C9 FRT82B/TM6B, w; stat92E 06346 FRT82B/TM6B, w; wts X1 stat92E 85C9 FRT82B/TM6B, or w; wts X1 stat92E 06346 FRT82B/TM6B. Six-to eight-dayold (at 18 C) adult females were then heat shocked at 37 C for 35 min and kept at 25 C until dissection. For hop-RNAi, we used vdrc102830. A substantial increase in esg+ cells was observed in a small fraction (approximately 1/15) of intestines in both experimental and control animals. We suspect that this sporadic phenotype reflects stimulation of ISC proliferation by ingested microbes [6] [7] [8] [9] [10] 13] , and we focused only on phenotypes that consistently correlated with experimental manipulations. As negative controls, we used flies lacking the relevant UAS or Gal4 transgene, and temperature shifted in parallel. In addition, we also performed control experiments for all TARGET genotypes in which flies were not shifted to the permissive temperature for expression.
Bleomycin Feeding Experiments
Bleomycin (Sigma) treatment was done as described previously [11] by mixing bleomycin into instant food (final concentration 25 mg/mL) and feeding it to flies cultured at 29 C; flies were transferred daily into new vials with fresh bleomycin. For RNAi experiments, MyoIA-Gal4/Cyo; Tub-Gal80ts/TM6b was crossed to y w hs-FLP; UAS-yki RNAi (vdrc104523)/CyO; UAS-dcr2/ TM6b, and 3-to 4-day-old adult females were shifted to 29 C for 5-8 days before transferring to bleomycin at 29 C for 2 more days.
Histology and Imaging
Posterior midguts of adult females were dissected in phosphate-buffered saline, fixed in 4% paraformaldehyde for 45 min, and then stained with antibodies, as described previously [32] , using mouse anti-Arm 
